Suppr超能文献

相似文献

2
Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
J Pharmacol Toxicol Methods. 2013 Jan-Feb;67(1):33-44. doi: 10.1016/j.vascn.2012.10.002. Epub 2012 Oct 26.
3
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):189-99. doi: 10.1016/j.vascn.2006.02.003. Epub 2006 Mar 6.
4
Comparison of human Ether-à-go-go related gene screening assays based on IonWorks Quattro and thallium flux.
Assay Drug Dev Technol. 2010 Dec;8(6):755-65. doi: 10.1089/adt.2010.0267. Epub 2010 Jul 26.
5
Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp.
BMC Pharmacol Toxicol. 2015 Dec 16;16:39. doi: 10.1186/s40360-015-0042-9.
6
Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
Assay Drug Dev Technol. 2005 Feb;3(1):47-57. doi: 10.1089/adt.2005.3.47.
7
Compilation and physicochemical classification analysis of a diverse hERG inhibition database.
J Comput Aided Mol Des. 2016 Dec;30(12):1175-1188. doi: 10.1007/s10822-016-9986-0. Epub 2016 Oct 25.
10
Global analysis reveals families of chemical motifs enriched for HERG inhibitors.
PLoS One. 2015 Feb 20;10(2):e0118324. doi: 10.1371/journal.pone.0118324. eCollection 2015.

引用本文的文献

1
Molecular Docking and In Vitro Evaluation of Violacein-Alginate Beads for Targeted Inhibition of Biofilm Formation.
ACS Omega. 2025 Jul 16;10(29):31827-31839. doi: 10.1021/acsomega.5c03106. eCollection 2025 Jul 29.
5
On QSAR-based cardiotoxicity modeling with the expressiveness-enhanced graph learning model and dual-threshold scheme.
Front Physiol. 2023 May 9;14:1156286. doi: 10.3389/fphys.2023.1156286. eCollection 2023.
6
Ensemble of structure and ligand-based classification models for hERG liability profiling.
Front Pharmacol. 2023 Mar 23;14:1148670. doi: 10.3389/fphar.2023.1148670. eCollection 2023.
8
Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment.
ACS Pharmacol Transl Sci. 2022 Nov 2;5(11):1197-1209. doi: 10.1021/acsptsci.2c00178. eCollection 2022 Nov 11.
9
New Insights into Ion Channels: Predicting hERG-Drug Interactions.
Int J Mol Sci. 2022 Sep 14;23(18):10732. doi: 10.3390/ijms231810732.
10
The Effect of a Synthetic Estrogen, Ethinylestradiol, on the hERG Block by E-4031.
Biomolecules. 2021 Sep 20;11(9):1385. doi: 10.3390/biom11091385.

本文引用的文献

1
Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.
Cell. 2015 Jun 4;161(6):1252-65. doi: 10.1016/j.cell.2015.05.023.
2
Global analysis reveals families of chemical motifs enriched for HERG inhibitors.
PLoS One. 2015 Feb 20;10(2):e0118324. doi: 10.1371/journal.pone.0118324. eCollection 2015.
3
Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects.
Acta Pharmacol Sin. 2014 Dec;35(12):1473-84. doi: 10.1038/aps.2014.101. Epub 2014 Nov 24.
4
Computational tools for fitting the Hill equation to dose-response curves.
J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:68-76. doi: 10.1016/j.vascn.2014.08.006. Epub 2014 Aug 23.
5
Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.
Acta Pharmacol Sin. 2014 Aug;35(8):1093-102. doi: 10.1038/aps.2014.35. Epub 2014 Jun 30.
7
Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.
J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):88-96. doi: 10.1016/j.vascn.2013.04.004. Epub 2013 Apr 25.
8
hERG channel function: beyond long QT.
Acta Pharmacol Sin. 2013 Mar;34(3):329-35. doi: 10.1038/aps.2013.6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验